Pediatrix Acquires Tampa Bay Maternal Fetal Group Practice

  
    
  
  
    
      Pediatrix Medical Group, Inc. (NYSE: PDX) has introduced additional 
      physician subspecialty services in the Tampa Bay area with the 
      acquisition of Florida Perinatal Associates, a maternal-fetal medicine 
      group practice.
    
    
      The seven physicians, who practice along with more than 27 clinical and 
      administrative staff members, provide patient care at offices in Tampa, 
      Clearwater and Sarasota, on Florida’s West Coast, and in Brevard County 
      on Florida’s East Coast.
    
    
      “We’re excited about moving forward as part of Pediatrix to respond to 
      increasing demand for maternal-fetal services throughout Tampa Bay, as 
      well as to surrounding areas throughout west and central Florida,” said 
      Jeffrey Angel, M.D., who founded Florida Perinatal Associates in 1992 
      and will serve as the practice medical director. “We’ll be able to work 
      with Pediatrix’s pediatric cardiology and neonatal subspecialists to 
      provide a continuum of care model that should improve fetal and newborn 
      health for patients in the communities we serve.”
    
    
      Pediatrix’s national group practice already includes neonatal and 
      pediatric cardiology physician subspecialists practicing in the Tampa 
      Bay area.
    
    
      Pediatrix paid cash for the practice, which is expected to contribute to 
      the Company’s results immediately.
    
    
      During 2008, Pediatrix has completed 13 physician group practice 
      acquisitions including four neonatal, four maternal-fetal, three 
      pediatric cardiology and two anesthesia group practices.
    
    
      About Pediatrix
    
    
      Pediatrix Medical Group, Inc. is the nation’s leading provider of 
      neonatal, maternal-fetal and pediatric physician subspecialty services 
      and recently expanded to include anesthesiology services. Pediatrix 
      physicians and advanced practitioners are reshaping the delivery of care 
      within the maternal-fetal, neonatal intensive care and pediatric 
      cardiology subspecialties, using evidence-based tools, continuous 
      quality initiatives and clinical research to enhance patient outcomes 
      and provide high-quality, cost-effective care. Founded in 1979, its 
      neonatal physicians provide services at more than 250 neonatal intensive 
      care units, and in many markets they collaborate with affiliated 
      maternal-fetal medicine, pediatric cardiology physician subspecialists 
      and pediatric intensivists to provide a clinical care continuum. 
      Combined, Pediatrix and its affiliated professional corporations employ 
      more than 1,200 physicians in 32 states and Puerto Rico. Pediatrix is 
      also the nation’s largest provider of newborn hearing screens. 
      Additional information is available at www.pediatrix.com.
    
    
      Certain statements and information in this press release may be 
      deemed to be “forward-looking statements” within the meaning of the 
      Federal Private Securities Litigation Reform Act of 1995. Forward-looking 
      statements may include, but are not limited to, statements relating to 
      our objectives, plans and strategies, and all statements (other than 
      statements of historical facts) that address activities, events or 
      developments that we intend, expect, project, believe or anticipate will 
      or may occur in the future are forward-looking statements. These 
      statements are often characterized by terminology such as “believe”, 
      “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, 
      “expect”, “estimate”, “project”, “positioned”, “strategy” and similar 
      expressions, and are based on assumptions and assessments made by 
      Pediatrix’s management in light of their experience and their perception 
      of historical trends, current conditions, expected future developments 
      and other factors they believe to be appropriate. Any forward-looking 
      statements in this press release are made as of the date hereof, and 
      Pediatrix undertakes no duty to update or revise any such statements, 
      whether as a result of new information, future events or otherwise. 
      Forward-looking statements are not guarantees of future performance and 
      are subject to risks and uncertainties. Important factors that could cause 
      actual results, developments, and business decisions to differ 
      materially from forward-looking statements are described in Pediatrix’s 
      most recent Annual Report on Form 10-K, including the section entitled 
      “Risk Factors”.